Holen Sie sich die Stockscreener-App
8.52
4.93%
0.40
Handel nachbörslich:
8.53
0.010
+0.12%
Schlusskurs vom Vortag:
$8.12
Offen:
$8.12
24-Stunden-Volumen:
193.20K
Relative Volume:
1.21
Marktkapitalisierung:
$173.04M
Einnahmen:
$56.13M
Nettoeinkommen (Verlust:
$-14.67M
KGV:
-11.51
EPS:
-0.74
Netto-Cashflow:
$-9.13M
1W Leistung:
+6.23%
1M Leistung:
+16.23%
6M Leistung:
+21.19%
1J Leistung:
+38.09%
1-Tages-Spanne:
$8.045
$8.665
1-Wochen-Bereich:
$7.67
$8.665
52-Wochen-Spanne:
$3.535
$8.8999
Journey Medical Corp Stock (DERM) Company Profile
Firmenname
Journey Medical Corp
Sektor
Telefon
480-434-6670
Adresse
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Vergleichen Sie DERM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
8.52 | 213.64M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-25 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-30 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-06-28 | Fortgesetzt | ROTH MKM | Buy |
| 2021-12-07 | Eingeleitet | B. Riley Securities | Buy |
Journey Medical Corp Aktie (DERM) Neueste Nachrichten
Can Journey Medical Corporation stock attract ESG capital inflowsDollar Strength & Fast Entry High Yield Stock Tips - newser.com
Journey Medical Corporation (NASDAQ:DERM) Given Average Rating of "Hold" by Brokerages - MarketBeat
Can a trend reversal in Journey Medical Corporation lead to recoveryPortfolio Risk Summary & Safe Entry Trade Signal Reports - newser.com
Health Equity - AstraZeneca
Why Journey Medical Corporation stock is recommended by analysts2025 Trading Volume Trends & Weekly Top Gainers Alerts - newser.com
Heatmap analysis for Journey Medical Corporation and competitorsJuly 2025 News Drivers & Daily Profit Maximizing Tips - newser.com
Analyzing Journey Medical Corporation with multi timeframe chartsOil Prices & Short-Term High Return Ideas - newser.com
Price momentum metrics for Journey Medical Corporation explainedJuly 2025 Macro Moves & Weekly High Return Stock Forecasts - newser.com
How Journey Medical Corporation stock reacts to Fed rate cuts2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Will Quipt Home Medical Corp. stock outperform value stocksWall Street Watch & Daily Stock Momentum Reports - Fundação Cultural do Pará
Short interest data insights for Journey Medical CorporationJuly 2025 Highlights & Low Risk Entry Point Tips - newser.com
Published on: 2025-10-27 18:20:54 - fcp.pa.gov.br
How Netflix Inc. stock performs in weak economyJuly 2025 Opening Moves & High Accuracy Swing Entry Alerts - fcp.pa.gov.br
Automated trading signals detected on Journey Medical CorporationPortfolio Performance Summary & Technical Confirmation Trade Alerts - newser.com
Using RSI to spot recovery in Journey Medical CorporationPortfolio Value Summary & Advanced Swing Trade Entry Alerts - newser.com
Will Journey Medical Corporation stock see insider buying2025 Market Overview & AI Forecast for Swing Trade Picks - newser.com
Volatility clustering patterns for Journey Medical CorporationNew Guidance & AI Driven Stock Movement Reports - newser.com
Journey Medical (NASDAQ:DERM) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Journey Medical’s Emrosi shows superior efficacy for rosacea - Investing.com
Houston Physician Dr. Rodolfo Giraldi Establishes National Scholarship to Cultivate the Next Generation of Medical Practitioners - Cantech Letter
Journey Medical Corporation Announces FDA Approval and Efficacy Results of Emrosi for Rosacea Treatment at 2025 Fall Clinical Dermatology Conference - Quiver Quantitative
Journey Medical (NASDAQ: DERM) Phase 3 pooled data: Emrosi cut lesions by 19.2 - Stock Titan
Fortress Biotech, Inc. (FBIO) Stock Price, News, Quote & History - Yahoo
Journey Medical Corporation (DERM) Stock forecasts - Yahoo
Finanzdaten der Journey Medical Corp-Aktie (DERM)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):